Search
Search Results
##search.searchResults.foundPlural##
-
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1120PDF: 586HTML: 6786 -
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
2679PDF: 977HTML: 399TABLE: 170FIGURES: 211 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3478PDF: 1446HTML: 4298CoverLetter: 170Figure1: 177 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1126PDF: 803HTML: 2165Figue 1: 163 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2092PDF: 1532HTML: 248 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
1912PDF: 791HTML: 2187Table 1: 158Table 2: 178Table 3: 171Table 4: 176Table 5: 172Tble 6: 166Cover Letter: 188Greene Tab.7: 169 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3680PDF: 1421HTML: 463Figures . Eliassian: 204 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3445PDF: 2349HTML: 1411 -
-
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1613PDF: 1131HTML: 230 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3238PDF: 1431HTML: 3982 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1537PDF: 552HTML: 213 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1099PDF: 878HTML: 281 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2378PDF: 1260HTML: 1723CoverLetter: 160 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
1983PDF: 1466HTML: 259 -
-
-
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4569PDF: 2742HTML: 2250 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2746PDF: 901HTML: 7304 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4567PDF: 1286HTML: 1889Untitled: 168Untitled: 163 -
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2224PDF: 1304HTML: 17060Bassan Fig.1: 133Bassan Fig.2: 131Bassan Fig.4: 126Fig.3: 168 -
-







